Researchers: Natalia Mota-Martorell, Mariona Jové, Reinald Pamplona
Decreased content and activity of the mechanistic target of rapamycin (mTOR) signalling pathway, as well as the mTOR complex 1 (mTORC1) itself, are key traits for animal species and human longevity. Since mTORC1 acts as a master regulator of intracellular metabolism, it is responsible, at least in part, for the longevous phenotype. Conversely, increased content and activity of mTOR signalling and mTORC1 are hallmarks of ageing. Additionally, constitutive and aberrant activity of mTORC1 is also found in age-related diseases such as Alzheimer’s disease (AD) and cancer. The downstream processes regulated through this network are diverse, and depend upon nutrient availability. Hence, multiple nutritional strategies capable of regulating mTORC1 activity and, consequently, delaying the ageing process and the development of age-related diseases, are under continuous study. Among these, the restriction of calories is still the most studied and robust intervention capable of downregulating mTOR signalling and feasible for application in the human population.
References
- Hypothalamic mTORC2 is essential for metabolic health and longevity.
- With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging.
- mTOR as a central regulator of lifespan and aging.
- Gene expression and regulatory factors of the mechanistic target of rapamycin (mTOR) complex 1 predict mammalian longevity.
- Age-dependent effects of caloric restriction on mTOR and ubiquitin-proteasome pathways in skeletal muscles.
- Ganoderma lucidum stimulates autophagy-dependent longevity pathways in Caenorhabditis elegans and human cells.
- Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.
- Clinical Trials Targeting Aging.
- The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging.